The Impact of Residual Thrombosis on the Long-Term Outcome of Patients with Deep Venous Thrombosis Treated with Conventional Anticoagulation
Anthonie Lensing(University of Amsterdam), Paolo Prandoni(University of Padua), Sabina Villalta(Ca' Foncello Hospital), Franco Noventa(University of Padua), Valentina Vedovetto(University of Padua), Daniela Tormene, Maria Sartori(Istituto Ortopedico Rizzoli), Raffaele Pesavento(University of Padua), Job Harenberg(Heidelberg University), Martin H. Prins(Maastricht University), Andrea Piccioli(Istituto Superiore di Sanità), Marta Milan(University of Padua)
Cited by 99
Related Papers
Recurrent venous thromboembolism and bleeding complications during anticoagulant treatment in patients with cancer and venous thrombosis
|Blood|2002|1.9k
Morbidity and mortality in compensated cirrhosis type C: A retrospective follow-up study of 384 patients
|Gastroenterology|1997|1.4k
A risk assessment model for the identification of hospitalized medical patients at risk for venous thromboembolism: the Padua Prediction Score
|Journal of Thrombosis and Haemostasis|2010|1.2k
The risk of recurrent venous thromboembolism after discontinuing anticoagulation in patients with acute proximal deep vein thrombosis or pulmonary embolism. A prospective cohort study in 1,626 patients
|Haematologica|2007|774
Editor's Choice – European Society for Vascular Surgery (ESVS) 2021 Clinical Practice Guidelines on the Management of Venous Thrombosis
|European Journal of Vascular and Endovascular Surgery|2020|709